At #BIO2025, Michael Boyne, Co-founder and Principal at CatalystBio, spoke…

At #BIO2025, Michael Boyne, Co-founder and Principal at CatalystBio, spoke on clinical trial development in the U.S. as part of a panel examining regional approaches to conducting trials and the diverse opportunities available across different countries. The audience also heard valuable insights from Jinhak Kim…  

​ 

Related Posts